article thumbnail

Esperion Presents New Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL

DAIC

18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with Peripheral Artery Disease (PAD) who were unable or unwilling to take statin medications. tim.hodson Tue, 12/03/2024 - 16:52 Nov. These data were presented at the 2024 American Heart Association Scientific Sessions, in Chicago, IL.

article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

IntroductionThere is growing evidence that patients with SARS-CoV-2 (The severe acute respiratory syndrome coronavirus 2) may have a variety of cardiovascular complications in the post-acute phase of COVID-19, but these manifestations have not yet been comprehensively characterized.MethodsWe performed a systematic review and meta-analysis of primary (..)

article thumbnail

New Tool Helps Predict Stroke Outcome with Higher Accuracy

DAIC

By integrating a real-time frailty risk score into the electronic medical record (EMR), presenting stroke severity and other variables, we can proactively identify who will benefit from immediate surgery and who may need pre-habilitating before surgery to achieve better outcomes.

Stroke 52
article thumbnail

Pregnancy and cardiovascular outcomes among patients post Fontan surgery: a 25-year single-centre retrospective cohort study

Open Heart

Introduction Data on the characteristics and outcomes of pregnancy and among patients with Fontan physiology are limited. We aimed to evaluate the immediate and long-term outcomes among these patients who were followed at our centre. We examined maternal and obstetric outcomes.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. From Research to Real-World Care 🌎 Understand how AI-driven advancements are shaping personalized treatments and patient outcomes. But its impact goes far beyond research.

article thumbnail

Prevalence and predictors of poor heart failure treatment outcomes in Ethiopia: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Various factors can exacerbate disease progression in patients with HF and negatively impact treatment outcomes. Publication bias was assessed using Begg's test, Egger's weighted regression, and funnel plots.ResultsThe pooled prevalence of poor HF treatment outcomes was found to be 16.67% [95% confidence interval (CI): 10.6722.67].

article thumbnail

Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk

Heart BMJ

Background In patients with tricuspid regurgitation (TR), delayed surgical intervention is associated with poor outcomes, particularly in advanced stages. Patients were stratified using the the Tricuspid Regurgitation Impact on Outcomes (TRIO) Score (for general health risk) and TRI-SCORE (for perioperative risk).